HyperVOPTICA: Feasibility of Measurement of Optical Aberrations in Hyperopia by Using an Adaptive Optics Visual Simulator (AOVIS-I)

Sponsor
University Hospital, Toulouse (Other)
Overall Status
Terminated
CT.gov ID
NCT01884805
Collaborator
Centre de Référence National du Kératocône (Other)
9
1
1
6
1.5

Study Details

Study Description

Brief Summary

The primary purpose of the protocol is to evaluate the adaptive optics visual simulator to measure optical aberrations in hyperopic eyes.

The study hypotheses are the:
  • Ability to measure optical aberrations in hypermetropia.

  • Knowledge of optical aberrations of the eye hyperopic.

  • To adapt therapeutic management in optical aberrations measured.

Condition or Disease Intervention/Treatment Phase
  • Device: Monocular Adaptive Optics Visual Simulator (AOVIS-I)
N/A

Detailed Description

The procedure is guided by the custom made software and its graphical user interface. The interface has been designed to be user-friendly, being very similar to the software usually managed by the clinicians in their daily professional practice. The complete procedure in one patient takes less than 5 minutes and is completely non-invasive. The optical measurements only involve the use of low power infrared laser and the visual testing is as simple for the patients as watching television and making responses.

Study Design

Study Type:
Interventional
Actual Enrollment :
9 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Feasibility of Measurement of Optical Aberrations in Hyperopia by Using an Adaptive Optics Visual Simulator (AOVIS-I)
Study Start Date :
Mar 1, 2013
Actual Primary Completion Date :
Sep 1, 2013
Actual Study Completion Date :
Sep 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Other: Monocular Adaptive Optics Visual Simulator (AOVIS-I)

Device: Monocular Adaptive Optics Visual Simulator (AOVIS-I)
The procedure is guided by the custom made software and its graphical user interface. The interface has been designed to be user-friendly, being very similar to the software usually managed by the clinicians in their daily professional practice. The complete procedure in one patient takes less than 5 minutes and is completely non-invasive. The optical measurements only involve the use of low power infrared laser and the visual testing is as simple for the patients as watching television and making responses.

Outcome Measures

Primary Outcome Measures

  1. Measurement of optical aberrations [1 day (Participants will be followed for the duration of ophtalmology consultation)]

    Feasibility of Measurement of optical aberrations in hyperopia by using an Adaptive Optics Visual Simulator AOVIS-I. Outcome measure is assessed during a consultation

Secondary Outcome Measures

  1. Reproductibility of the measures [1 day (Participants will be followed for the duration of ophtalmology consultation)]

    Evaluate the reproducibility of the measures obtained in hyperopic eyes. Outcome measure is assessed during a consultation

  2. Quantitative measurement of optical aberrations [1 day (Participants will be followed for the duration of ophtalmology consultation)]

    Expression of optical aberrations in numerical measures. Outcome measure is assessed during a consultation

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • hyperopic patients

  • to be able to understand an information and give a consent

  • affiliated to medical insurance

Exclusion Criteria:
  • pregnant women or nursing mothers

  • ocular infection

  • keratitis

  • restless patients

  • ocular surgery 90 days before inclusion

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital, Toulouse Toulouse Midi-Pyrenees France 31059

Sponsors and Collaborators

  • University Hospital, Toulouse
  • Centre de Référence National du Kératocône

Investigators

  • Principal Investigator: François MALECAZE, PHD,

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University Hospital, Toulouse
ClinicalTrials.gov Identifier:
NCT01884805
Other Study ID Numbers:
  • 12 483 03
First Posted:
Jun 24, 2013
Last Update Posted:
Jul 16, 2019
Last Verified:
Jul 1, 2019
Keywords provided by University Hospital, Toulouse
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 16, 2019